Heat shock proteins are categorized by molecular weight (e.g., Hsp70, Hsp90) or gene families (e.g., HSPA for Hsp70, HSPB for small Hsps). The number "14.7" does not correspond to any recognized Hsp family or isoform in current literature . Potential explanations for the term include:
Typographical error: Possible confusion with HSPA14 (a member of the Hsp70 family) or HSPB1 (Hsp27).
Proprietary designation: Unpublished or commercial antibody names not yet cataloged in public databases.
While "HSP14.7" remains unidentified, several well-characterized Hsp antibodies are documented:
Role: HSPA14 interacts with HspBP1 to inhibit HIV-1 replication by modulating transcriptional pathways .
Antibody Relevance: Studies demonstrate that HSPA14 antibodies are downregulated during HIV infection, correlating with viral load (Table 1) .
| Study Parameter | High Viral Load (HVL) | Low Viral Load (LVL) | Significance |
|---|---|---|---|
| HSPA14 mRNA expression | Reduced | Elevated | |
| NF-κB activation | Increased | Baseline | Correlates with EBA severity |
Clinical Association: Anti-Hsp70 IgG autoantibodies are elevated in autoimmune diseases like epidermolysis bullosa acquisita (EBA) and correlate with IFN-γ levels .
Mechanism: Enhance neutrophil infiltration and NF-κB signaling in murine EBA models .
Biomarker Potential: Serum anti-Hsp27 titers correlate with inflammatory markers (PAL, TG) in ensemble machine learning models .
Detection: Validated via Western blot and Simple Western™ assays .
The absence of "HSP14.7 Antibody" in literature suggests:
Validation Needed: Confirm the target protein’s identity and cross-reference with established Hsp designations.
Exploratory Studies: Screen existing Hsp antibody libraries (e.g., StressMarq’s Anti-HSP70 [1H11] , Cell Signaling’s #4872 ) for cross-reactivity.
Technical Clarification: Verify whether "14.7" refers to molecular weight (kDa), epitope specificity, or a proprietary identifier.
Heat shock protein antibodies relevant to research include HSP17.7 (class II cytosolic) antibodies for plant studies and HSP70/HSP7C antibodies for mammalian systems. HSP17.7 antibody is generated as a polyclonal antibody in rabbits using full-length recombinant protein produced in E. coli without affinity tags . In contrast, HSP70 antibody is typically produced as a mouse monoclonal antibody against recombinant protein fragments from human HSPA1A . A novel anti-HSP7C (HSPA8) antibody has been identified in patients with Kawasaki Disease, demonstrating the diversity of these research tools .
HSP17.7 antibody demonstrates confirmed reactivity with multiple plant species including Arabidopsis thaliana, Agave tequiliana var. Weber, Cucumis sativus, Medicago sativa, Pinellia ternata, and Silene vulgaris . Interestingly, it shows predicted reactivity with dicots and Fraxinus sp. but is not reactive in Oryza sativa or Polyscias elegans, highlighting important species limitations . HSP70 antibody shows broader cross-reactivity, detecting proteins in human, mouse, and Saccharomyces cerevisiae samples . Understanding these reactivity profiles is essential when designing experiments involving different model organisms.
Each heat shock protein antibody targets proteins with distinctive molecular weights and characteristics. HSP17.7 antibody targets a protein with an expected molecular weight of 17.7 kDa, though interestingly it can also detect SDS-resistant dimers at approximately 38 kDa . HSP70 antibody detects a protein with a predicted and observed band size of 70 kDa . HSP7C/HSPA8 antibody targets a protein of approximately 70 kDa that shares 19% protein sequence coverage with HSP7C . These molecular characteristics determine the appropriate experimental conditions for detection and analysis.
For optimal Western blot detection using HSP17.7 antibody, researchers should load 15 μg of total protein from control and heat-shocked samples on 15% SDS-PAGE gels . After transferring to nitrocellulose for 1 hour, membranes should be incubated with primary antibody at 1:1000 dilution for 1 hour at room temperature with agitation . Secondary HRP-conjugated antibody should be used at 1:10,000 dilution, followed by chemiluminescent detection . For HSP70 antibody, use 1 μg/mL concentration with 30 μg of whole cell lysate and Goat anti-Mouse IgG H+L (HRP) at 1:4000 dilution . These optimized conditions ensure specific detection while minimizing background signal.
For immunofluorescence studies using HSP70 antibody, fix cells with formalin and permeabilize with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature . Block with 3% BSA-PBS for 30 minutes at room temperature before incubating with primary antibody at 1:100 dilution overnight in a humidified chamber . After washing with PBS, incubate with DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark . Counter-stain F-actin with fluorescent phalloidin (red) and nuclei with DAPI (blue), then image at 60X magnification . This protocol enables visualization of subcellular localization patterns of heat shock proteins under various experimental conditions.
For ELISA detection of anti-heat shock protein antibodies in serum samples, coat 96-well microplates with purified protein (e.g., HSP7C) at 500 ng/ml in carbonate-bicarbonate buffer (0.05 M; pH 9.6) overnight at 4°C . Block wells with 10% goat serum at 37°C for 2 hours before adding serum samples diluted 1:100 in 0.1% PBST . Incubate for 2 hours at 37°C, wash five times with 0.3% PBST, then add goat HRP-conjugated anti-human IgG secondary antibody (1:10,000) for 1 hour at 37°C . Develop with tetramethylbenzidine for 5 minutes at 25°C and stop the reaction with 2 M H₂SO₄ before reading at 450 nm with a reference wavelength of 620 nm .
For effective immunoprecipitation of heat shock proteins like HSP70, form antigen-antibody complexes by incubating 500 μg of whole cell lysate with 2 μg of antibody overnight on a rocking platform at 4°C . Capture immune complexes on 50 μl Protein A/G Agarose and elute with appropriate buffer . Resolve samples on a 4-20% Tris-HCl polyacrylamide gel, transfer to PVDF membrane, and block with 5% BSA/TBST for at least 1 hour . Probe with primary antibody at 1:1000 dilution overnight at 4°C, followed by goat anti-mouse IgM secondary antibody at 1:20,000 dilution for at least 1 hour . This approach effectively isolates heat shock protein complexes for further analysis of interaction partners.
Heat shock protein antibodies provide powerful tools for analyzing stress responses in plants. For example, HSP17.7 antibody has been successfully used to compare protein expression between heat-shocked (38°C for 2 hours) and control Arabidopsis thaliana plants . The antibody detects both monomeric (17.7 kDa) and dimeric (38 kDa) forms of the protein, providing insights into protein aggregation and oligomerization under stress conditions . This approach can be extended to study responses to other abiotic stressors such as drought, salinity, or heavy metal exposure by comparing expression patterns across various treatment conditions and recovery periods.
Anti-heat shock protein antibodies have significant potential as biomarkers in human disease research. Studies have identified a novel anti-HSP7C antibody in patients with Kawasaki Disease (KD) . When evaluating this antibody's diagnostic potential using ROC curve analysis, researchers found it could differentiate KD patients from febrile controls with an area under the curve (AUC) of 0.691 (95% CI, 0.584–0.785; P=0.0006), showing 60.00% sensitivity and 78.95% specificity . The antibody demonstrated even stronger performance in distinguishing KD patients from healthy controls with an AUC of 0.848 (95% CI, 0.756–0.916; P=0.0001), 60.00% sensitivity and 97.37% specificity . This research approach identifies potential serological markers that could aid in clinical diagnosis and understanding of disease mechanisms.
When analyzing heat shock proteins by Western blot, researchers often observe bands at unexpected molecular weights. For example, HSP17.7 can form SDS-resistant dimers visible at approximately 38 kDa . These observations are not artifacts but rather provide valuable information about protein oligomerization and complex formation. Several experimental approaches can help distinguish true dimers from non-specific bands: (1) Compare heat-shocked versus control samples to identify stress-induced changes in oligomerization, (2) Include recombinant protein standards of known concentration, (3) Perform mass spectrometry validation of bands, and (4) Use native gel electrophoresis as a complementary approach to study physiological protein complexes.
Analysis of anti-HSP7C antibody levels in Kawasaki Disease patients revealed a significant correlation with platelet counts . Patients with higher anti-HSP7C antibody levels (ELISA cut-off value >0.267) had significantly lower platelet counts (355.5±140.8×10⁹/l) compared to those with lower antibody levels (461.6±128.0×10⁹/l, P=0.0094) . This correlation is particularly notable as platelet count has been previously associated with coronary artery lesion development in KD patients . Such findings suggest that autoantibodies against heat shock proteins may play mechanistic roles in disease pathogenesis, possibly through inflammatory pathways or immune complex formation, rather than being merely secondary phenomena.
Several factors can influence cross-species reactivity of heat shock protein antibodies: (1) Sequence conservation - while heat shock proteins are generally conserved, specific epitopes may vary (HSP17.7 antibody shows reactivity with several plant species but not with Oryza sativa or Polyscias elegans) , (2) Post-translational modifications that may differ between species, (3) Protein extraction methods may require optimization for different tissue types, and (4) Expression levels vary naturally between species and tissues. When working with understudied organisms, researchers should perform preliminary validation experiments and consider using multiple antibodies targeting different epitopes of the same protein.
Determining optimal antibody dilutions for new applications requires systematic titration experiments. For HSP17.7 antibody, the recommended dilution for Western blot is 1:1000 , while HSP70 antibody can be used at 1 μg/mL for Western blot and 1:100 for immunofluorescence . When developing a new application, begin with the manufacturer's recommended dilution, then test a range spanning at least 2-fold higher and lower concentrations. Include appropriate positive and negative controls (e.g., heat-shocked versus control samples, recombinant protein standards, and secondary-only controls). Evaluate both signal strength and background levels to determine the optimal dilution that maximizes signal-to-noise ratio while conserving antibody.
Quantitative analysis of heat shock protein expression from Western blots should include several key steps: (1) Include a standard curve using recombinant protein at known concentrations (e.g., 1, 2, 5, and 10 ng of HSP17.7) , (2) Use digital image analysis software to perform densitometry on bands of interest, (3) Normalize signal to appropriate loading controls, (4) Account for both monomeric and potential dimeric forms when assessing total protein levels, and (5) Apply appropriate statistical analysis when comparing multiple conditions. This approach provides robust quantification that accounts for technical variations and allows meaningful comparisons between experimental conditions.
When analyzing heat shock protein antibodies as potential biomarkers, robust statistical approaches are essential. For example, in studies of anti-HSP7C antibodies in Kawasaki Disease, researchers used ROC curve analysis to assess diagnostic potential . They determined optimal cutoff values by maximizing the Youden index, which balances sensitivity and specificity . When the cutoff optical density value was set at 0.267, the positive ratio of anti-HSP7C antibodies in KD, febrile control, and healthy control groups were 60.00% (30/50), 21.05% (8/38), and 5.26% (2/38), respectively . For comparing antibody levels between groups, appropriate parametric or non-parametric tests should be selected based on data distribution, with clear reporting of statistical significance (p-values).
Correlating heat shock protein levels with physiological or pathological outcomes requires careful experimental design and comprehensive data collection. In clinical research with anti-HSP7C antibodies, investigators found significant correlations between antibody levels and platelet counts in Kawasaki Disease patients . Similar approaches can be applied in basic research by: (1) Measuring heat shock protein levels across multiple timepoints following stress exposure, (2) Simultaneously assessing physiological parameters (growth rate, survival, photosynthetic efficiency in plants), (3) Using regression analysis to identify statistically significant relationships, and (4) Testing causality through genetic approaches (overexpression or knockdown of heat shock proteins). This integrated approach helps establish whether changes in heat shock protein levels are causative factors or merely correlative markers.